No Data
No Data
No Data
No Data
No Data
Express News | JMP Securities Reiterates Market Outperform on Rallybio, Maintains $8 Price Target
Moomoo 24/7Apr 18 13:18 ET
Rallybio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 346.93% JMP Securities → $8 Reiterates Market Outperform → Market Outperform 04/11/2024 514.53%
BenzingaApr 18 13:17 ET
Buy Rating Affirmed for Rallybio Amid Significant Market Opportunity in FNAIT Treatment
TipRanksApr 17 19:15 ET
Rallybio Corporation Announces FNAIT Systematic Literature Review And Meta-Analysis Presented At The Academy Of Managed Care Pharmacy 2024 Annual Meeting
- Data Support HPA-1a Negative Frequency of More than 2% in Nearly 200,000 Screened Pregnant Women -- Among HPA-1a Negative Pregnant Women, Approximately 33% are at Higher Risk for Alloimmunization -R
BenzingaApr 17 16:08 ET
12 Health Care Stocks Moving In Monday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) stock moved upwards by 44.4% to $2.44 during Monday's regular session. The market value of their outstanding shares is at $7.7 million. Mobile-health Network (NASDAQ:MN
BenzingaApr 15 12:31 ET
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals Among Healthcare Movers
Seeking AlphaApr 15 10:00 ET
No Data
No Data